Fungal infections in HIV/AIDS
Open accessThe DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Fungi are major contributors to the opportunistic infections that affect patients with HIV/AIDS. Systemic infections are mainly with Pneumocystis jirovecii (pneumocystosis), Cryptococcus neoformans (cryptococcosis), Histoplasma capsulatum (histoplasmosis), and Talaromyces (Penicillium) marneffei (talaromycosis). The incidence of systemic fungal infections has decreased in people with HIV in high-income countries because of the widespread availability of antiretroviral drugs and early testing for HIV. However, in many areas with high HIV prevalence, patients present to care with advanced HIV infection and with a low CD4 cell count or re-present with persistent low CD4 cell counts because of poor adherence, resistance to antiretroviral drugs, or both. Affordable, rapid point-of-care diagnostic tests (as have been developed for cryptococcosis) are urgently needed for pneumocystosis, talaromycosis, and histoplasmosis. Additionally, antifungal drugs, including amphotericin B, liposomal amphotericin B, and flucytosine, need to be much more widely available. Such measures, together with continued international efforts in education and training in the management of fungal disease, have the potential to improve patient outcomes substantially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIV/AIDS pandemic, tuberculosis, chronic obstructive pulmonary disease (COPD), asthma and the increasing incidence of cancers are the major drivers of fungal infections in both developed and developing countries globally [1,2,3,4,5,6].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [6]
In the citing paper
“Mortality of PCP ranges from 10–30% and can be even higher if the diagnosis is delayed [6].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [6]
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationWheat, L. J., Freifeld, A. G., Kleiman, M. B., Baddley, J. W., McKinsey, D. S., Loyd, J. E., & Kauffman, C. A. (2007) · Clinical Infectious Diseases · doi:10.1086/521259 · Cited by 1,386
Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Thomas, C. F., & Limper, A. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032588 · Cited by 1,037
Self-citationManual of Clinical Microbiology
(2011) · Wiley eBooks · doi:10.1128/9781555816728 · Cited by 1,003
Limper, A. H., Knox, K. S., Sarosi, G. A., Ampel, N. M., Bennett, J. E., Catanzaro, A., Davies, S. F., Dismukes, W. E., Hage, C. A., Marr, K. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2008-740st · Cited by 612
Self-citationDisseminated Penicillium marneffei infection in Southeast Asia
Supparatpinyo, K., Khamwan, C., Baosoung, V, Sirisanthana, T., & Nelson, K. E. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91287-4 · Cited by 607
Combination Antifungal Therapy for Cryptococcal Meningitis
Day, J. N., Chau, T. T. H., Wolbers, M., Mai, P. P., Dung, N. T., Mai, N. H., Phu, N. H., Nghia, H. D., Phong, N. D., Thai, C. Q., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1110404 · Cited by 545
Research works printed but not linked: 3
- Wong, 1998, Redefining AIDS: case exemplified by Penicillium marneffei infection in HIV-infected people in Hong Kong, Int J STD AIDS, 9, 555
- Le T, Jonat B, Kim Cuc NT, et al. The exposure and geospatial risk factors for AIDS-associated penicilliosis in Vietnam. Conference on Retroviruses and Opportunistic Infections; Seattle, WA, USA; Feb 23–26, 2015.
- Chariyalertsak, 1996, Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei, J Med V Med, 34, 105
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“Mortality of PCP ranges from 10–30% and can be even higher if the diagnosis is delayed [6].”
BackgroundAnti-Fungal Efficacy and Mechanisms of Flavonoids
Al Aboody, M. S., & Mickymaray, S. (2020) · Antibiotics · doi:10.3390/antibiotics9020045 · Cited by 472
Queiroz-Telles, F., Fahal, A. H., Falci, D. R., Caceres, D. H., Chiller, T., & Pasqualotto, A. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30306-7 · Cited by 314
Thompson, G. R., Le, T., Chindamporn, A., Kauffman, C. A., Alastruey-Izquierdo, A., Ampel, N. M., Andes, D. R., Armstrong-James, D., Ayanlowo, O., Baddley, J. W., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00191-2 · Cited by 311
Self-citationAdenis, A. A., Valdes, A., Cropet, C., McCotter, O. Z., Derado, G., Couppie, P., Chiller, T., & Nacher, M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30354-2 · Cited by 219
Self-citation
Metadata
- Authors
- Limper, A. H., Adenis, A., Le, T., & Harrison, T. S.
- Affiliations
- Mayo Clinic (US)
- Inserm (FR)
- University of Hawaiʻi at Mānoa (US)
- University of London (GB)
- Corresponding author
- Harrison, Thomas S
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 17
- Issue
- 11
- Pages
- e334-e343
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2740199405
- Cited by
- 472
- References
- 108
- Citations by year
- 2026: 27 · 2025: 54 · 2024: 58 · 2023: 70 · 2022: 55 · 2021: 65 · 2020: 62 · 2019: 44 · 2018: 31 · 2017: 6
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- HAL (submittedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Wellcome Trust
- Agence Nationale de la Recherche (ANR-10-LABX-0025)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Keywords
- fungal infection, HIV/AIDS, opportunistic infections, Pneumocystis carinii pneumonia, cryptococcosis, histoplasmosis, talaromycosis, Penicillium marneffei, antiretroviral therapy, CD4 count, point-of-care testing, antiretroviral resistance, amphotericin B, 5-fluorocytosine
- MeSH terms
- Antifungal Agents, Diagnostic Tests, Routine, Fungi, Humans, Mycoses, HIV Infections, Incidence, AIDS-Related Opportunistic Infections, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fungal infections in HIV/AIDS. https://app.cochat.ai/papers/10.1016/s1473-3099(17)30303-1
- The paper
- Limper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017). Fungal infections in HIV/AIDS. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(17)30303-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.